Retatrutide 20mg

Retatrutide is a research-grade glucagon-like peptide receptor triple agonist designed for studies in metabolic signaling and energy regulation. This novel compound targets GLP-1, GIP, and glucagon receptors simultaneously, enabling research into multi-receptor metabolic modulation.

Investigations have examined how triple agonism may produce synergistic effects beyond what single or dual receptor targeting can achieve. Research areas include appetite regulation pathways, pancreatic beta cell function, hepatic lipid metabolism, and energy expenditure. The compound’s multi-target approach makes it a valuable tool for studying the complex interplay between incretin hormones and glucagon in metabolic homeostasis.

Each vial contains 20mg of lyophilized GLP3-RT, synthesized under GMP conditions with purity exceeding 98% as confirmed by HPLC analysis. Quality verification includes mass spectrometry and endotoxin testing. Certificate of analysis available upon request.

Storage: Store lyophilized at -20°C. Reconstituted at 2-8°C, use within 60 days.

For research and laboratory use only.